Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT05171569

Post Discharge After Surgery Virtual Care With Remote Automated Monitoring Technology-3 Trial

The Post discharge after surgery Virtual Care with Remote Automated Monitoring technology (PVC-RAM)-3 Trial is a multicentre, parallel group, superiority, randomized controlled trial to determine the effect of virtual care with remote automated monitoring (RAM) technology compared to standard care on length of index hospital stay and use of acute hospital care (composite of hospital readmission and emergency department visit) after randomization, in adults who have undergone elective non cardiac surgery. Secondary outcomes at 30 days after randomization include: 1) hospital re-admission; 2) emergency department visit; 3) medication error detection;4) medication error correction; 5) surgical site infection; and 6) days in hospital. Additional secondary outcomes are pain of any severity, and moderate-to-severe pain assessed at 15 and 30 days after randomization. The investigators will also assess optimal management of long-term health by evaluating among patients with atherosclerotic disease and current smokers whether patients are taking classes of efficacious medications at 30 days.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hamilton General Hospital, Hamilton, Ontario, Canada

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • are ≥18 years of age;
  • are undergoing inpatient elective noncardiac surgery with an expected length of hospital stay ≤3 days after surgery; and
  • provide informed consent to participate.

Exclusion criteria

  • are unable to communicate with research staff, complete study surveys, or undertake an interview using a tablet computer due to a language barrier or a cognitive, visual, or hearing impairment; or
  • reside in an area without cellular network coverage.

Treatment and study plan

Virtual care with remote automated monitoring (RAM)

Device

Use of Cloud Diagnostics connected health kit for at home monitoring with virtual clinical from nursing and perioperative physician team.

Primary outcomes

  1. Index hospital length of stay

    Time frame: 30 Days post randomization

    Length of stay from randomization until discharge from the index hospitalization (measured in days and hours)

  2. Acute hospital care (composite of hospital readmission and emergency department visit)

    Time frame: 30 Days post randomization

    Acute-hospital care is a composite outcome of hospital re-admission and emergency department visit, which includes urgent-care centre visit.

Secondary outcomes

  1. Hospital readmission

    Time frame: 30 days post randomization

    Patient admission to an acute-care hospital.

  2. Emergency department visit (includes urgent care centre visit)

    Time frame: 30 days post randomization

    Patient visit to an emergency department, which includes urgent-care centre visit.

  3. Medication error detection

    Time frame: 30 days post randomization

    Medication errors include mistakes in medication prescribing, transcribing, dispensing, administering, or monitoring due to preventable events or actions taken by a patient, caregiver, or healthcare worker. Medication errors include: drug omission (i.e., patient did not take a drug they were supposed to take), drug commission (i.e., patient taking a drug they were not supposed to take), duration error, dosing error, frequency error, route error, and timing error. We will record all drug errors identified.

  4. Medication error correction

    Time frame: 30 days post randomization

    Any medication error that is corrected.

  5. Surgical site infection

    Time frame: 30 days post randomization

    Surgical site infection is an infection that occurs within 30 days after randomization and involves the skin, subcutaneous tissue of the incision (superficial incisional), or the deep soft tissue (e.g., fascia, muscle) of the incision (deep incisional).

  6. Days in hospital

    Time frame: 30 days post randomization

    Days in hospital

  7. Level of pain and pain related interference in recovery

    Time frame: 15 and 30 days post randomization

    Pain intensity and related interference with usual daily activities, will be measured via the Brief Pain Inventory-Short Form (BPI-SF).4 The BPI-SF includes four 11-point numeric rating scales (NRS) of pain intensity, which measure "average", "least", and "worst" pain intensity in the past 24 hours (hrs.), respectively, as well as pain intensity "now" (0= no pain, 10= pain as bad as you can imagine). The BPI-SF interference subscale will also be used, which measures the degree to which pain interferes with general activity, mood, walking, work, relations with others, sleep, and enjoyment of life (NRS for each item; 0=does not interfere, 10=completely interferes). A total interference score is determined by calculating the sum of these 7 items. The BPI-SF has strong psychometric properties with well-established reliability and validity across divergent surgical groups. Moderate to severe pain is defined by a score of ≥4/10 on a standard numeric rating scale (NRS) for pain.

  8. Optimization of medications for long-term health

    Time frame: 30 days post randomization

    Among patients with atherosclerotic disease, we will also assess optimal pharmacological management based upon whether patients are taking 0, 1, 2, or 3 of the following classes of efficacious medications at 30 days (i.e., an antiplatelet or anticoagulant drug; an angiotensin-converting enzyme inhibitor or angiotensin-receptor blocker; and a statin). Among active smokers before surgery we will assess if patients are receiving pharmacological smoking cessation interventions at 30 days after randomization.

Other outcomes

  1. Infection

    Time frame: 30 days post randomization

    Infection is defined as a pathologic process caused by the invasion of normally sterile tissue, fluid, or body cavity by pathogenic or potentially pathogenic organisms.

  2. Re-operation

    Time frame: 30 days post randomization

    Re-operation refers to any surgical procedure undertaken for any reason (e.g., wound dehiscence, infection).

  3. Composite of myocardial infarction, acute heart failure, and arrhythmia that results in acute hospital care

    Time frame: 30 days post randomization

    The diagnosis of myocardial infarction requires criteria meeting 4th universal definition of myocardial infarction.

    The definition of acute heart failure requires at least one of the following clinical signs (i.e., elevated jugular venous pressure, respiratory rales or crackles, crepitations, or presence of S3) with at least one of the following:

    • radiographic findings of vascular redistribution, interstitial pulmonary edema, or frank alveolar pulmonary edema, OR
    • heart failure treatment with a diuretic and documented clinical improvement.

    Any arrhythmia that results in patient presenting to an emergency department, which includes an urgent care centre visit or being admitted to hospital.

  4. Death

    Time frame: 30 days post randomization

    All cause mortality

  5. Health related quality of life (HRQoL)

    Time frame: 30 days post randomization

    HRQoL will be measured with the EQ-5D-5L instrument (https://euroqol.org/eq-5d-instruments/sample-demo) due to its increased sensitivity and validation in several countries including Canada.4 The EQ-5D-5L is also recommended in Canada5 to calculate the Quality Adjusted Life Years (QALYs) when conducting cost-effectiveness analyses.

  6. Health services utilization-related costs

    Time frame: 30 days post randomization

    Data on hospital re-admission, length of stay, and healthcare utilization will be obtained from the Ontario Hospital Association Integrated Decision Support (IDS) database. IDS is a comprehensive platform with an integrated view of patient activity, allowing for access to health systems data for any patients enrolled. Data on costs of health service utilization will be obtained from the Ontario Case Costing Database.

Sponsors and collaborators

Lead sponsor

Population Health Research Institute

Other

Collaborators

  • Hamilton Health Sciences Corporation

Registry information

Official study title

Post Discharge After Surgery Virtual Care With Remote Automated Monitoring Technology-3 (PVC-RAM-3) Trial

Acronym: PVC-RAM-3

Important dates

Study start
2021
Primary completion
2024
Study completion
2025
First posted
Dec 29, 2021
Registry last updated
Mar 27, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.